Source: United States & Canada – South China Morning PostPfizer Inc and BioNTech have asked US regulators to approve emergency use of their Covid-19 vaccine for children aged five to 11, Pfizer said in a tweet on Thursday.The US Food and Drug Administration has set a date of October 26 for its panel of outside advisers to meet and discuss the application, making it possible for kids to begin receiving the vaccines soon afterwards.A rapid authorisation of the vaccine in young kids could help mitigate a potential surge of cases this fall, with schools…Read More